{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:08:38Z","timestamp":1784099318319,"version":"3.55.0"},"reference-count":30,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>This study assessed pharmacists' experiences and perspectives on monitoring antidepressant adverse events. A stratified sample of 1000 community pharmacists in Dutch\u2010speaking Belgium was invited to complete an online survey on general views on adverse event monitoring and antidepressant adverse event monitoring practice at first and second dispensing and after 1\u2009year. Descriptive statistics were used for analysis. The response rate was 24.4% (244\/1000). Overall, pharmacists generally reported positive attitudes towards monitoring antidepressant adverse events, although less positive than for other medicines. Although pharmacists felt well\u2010positioned and trained to monitor adverse events, their approach remains largely passive. Most pharmacist informed patients at first dispensing, but only 47% proactively inquired at second dispensing and 9% at dispensing after 1\u2009year. Only 19% felt comfortable discussing sexual dysfunction. In conclusion, despite community pharmacists' positive perspectives, proactive monitoring declined over time highlighting the need for patient, healthcare provider and policy level interventions.<\/jats:p>","DOI":"10.1002\/bcp.70571","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:31:36Z","timestamp":1776666696000},"page":"2403-2408","source":"Crossref","is-referenced-by-count":0,"title":["A survey of community pharmacists perspectives on monitoring antidepressant adverse events"],"prefix":"10.1002","volume":"92","author":[{"given":"Ketura","family":"Verheye","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences Ghent University  Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Roesems","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences Ghent University  Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Van Caenegem","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences Ghent University  Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris F.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Specialist Mental Health and Advanced General Practice Pharmacist, Primary Care, Pharmacy Services National Health Service Greater Glasgow and Clyde  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1848-208X","authenticated-orcid":false,"given":"Els","family":"Mehuys","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Unit, Department of Bioanalysis, Faculty of Pharmaceutical Sciences Ghent University  Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Petrovic","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences Ghent University  Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Boussery","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Unit, Department of Bioanalysis, Faculty of Pharmaceutical Sciences Ghent University  Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Christiaens","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences Ghent University  Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3155-4095","authenticated-orcid":false,"given":"Ellen","family":"Van Leeuwen","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences Ghent University  Ghent Belgium"},{"name":"Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences Ghent University  Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/23.4.262"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.3399\/BJGPO.2021.0020"},{"key":"e_1_2_10_4_1","unstructured":"Directie Farmaceutisch Beleid Dienst voor Geneeskundige Verzorging.MORSE 2024 (gegevens 2022\u20102023).National Institute for Health and Disability Insurance (INAMI\u2010RIZIV);2024[cited 2025 May 26]. Available from:https:\/\/www.riziv.fgov.be\/SiteCollectionDocuments\/morse_report_2024.pdf"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3999"},{"key":"e_1_2_10_6_1","unstructured":"The Scottish Government.Quality prescribing for antidepressants: guide for improvement 2024 to 2027. Edinburgh:The Scottish Government;2024[cited 2025 May 26]. Available from:https:\/\/www.gov.scot\/publications\/quality-prescribing-antidepressants-guide-improvement-2024-2027\/"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp12X658304"},{"key":"e_1_2_10_8_1","first-page":"592","volume-title":"The Maudsley deprescribing guidelines: antidepressants, benzodiazepines, gabapentinoids and Z\u2010drugs","author":"Horowitz M","year":"2024"},{"key":"e_1_2_10_9_1","first-page":"872","volume-title":"The Maudsley prescribing guidelines in psychiatry","author":"Taylor D","year":"2018"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41999\u2010021\u201000475\u20107"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011405665"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2017.12.098"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed\u20102021\u2010000017"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12875\u2010014\u20100210\u20109"},{"key":"e_1_2_10_15_1","unstructured":"National Institute for Health and Care Excellence.Depression in adults: treatment and management (National Guideline 222).National Institute for Health and Care Excellence;2022[cited 2025 May 26]. Available from:https:\/\/www.nice.org.uk\/guidance\/ng222"},{"key":"e_1_2_10_16_1","volume-title":"NHG\u2010Standaard Depressie","author":"Claassen N","year":"2024"},{"key":"e_1_2_10_17_1","volume-title":"Richtlijn voor goede medische praktijkvoering: Depressie bij volwassenen","author":"Declercq T","year":"2017"},{"key":"e_1_2_10_18_1","unstructured":"InterMutualistisch Agentschap.IMA Atlas: Geneesmiddelengebruik Antidepressiva.Intermutualistisch Agentschap VZW;2022[cited 2025 May 26]. Available from:https:\/\/aim-ima.be\/IMA-Atlas"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S241780"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08443"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12875\u2010017\u20100643\u2010z"},{"key":"e_1_2_10_22_1","first-page":"506","volume-title":"The pharmacist guide to implementing pharmaceutical care","author":"Costa FA","year":"2019"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2018.09.002"},{"key":"e_1_2_10_24_1","unstructured":"World Health Organization.Joint FIP\/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services.World Health Organization;2011[cited 2025 May 26]. Available from:https:\/\/www.who.int\/publications\/m\/item\/annex-8-trs-961"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2008.59.10.1155"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S273365"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096\u2010012\u20109628\u20100"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/009262300278623"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.061960"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2022.01.014"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2014.07.180"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70571","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bcp.70571","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:33:20Z","timestamp":1784097200000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/bcp.70571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1002\/bcp.70571"],"URL":"https:\/\/doi.org\/10.1002\/bcp.70571","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,19]]}}}